Cognex Corporation filings document regulatory disclosures for an operating company focused on industrial machine vision products and automation technology. Its Form 8-K reports cover furnished operating results, quarterly cash dividends, share repurchase authorization, board and officer matters, annual meeting voting results, and changes in the company’s independent registered public accounting firm.
Proxy materials describe director elections, governance matters, executive compensation, shareholder voting procedures, and board committee oversight. The filing record also includes exhibit-based disclosures tied to financial-results releases and capital-return actions involving Cognex common stock.
Cognex Corporation CEO & President Matthew Moschner reported equity compensation activity involving restricted stock units and related tax withholding. On February 20 and 21, 2026, restricted stock units covering 3,042 and 3,495 shares were exercised into an equal number of Cognex common shares at $0.00 per share.
To satisfy tax withholding obligations on these vesting awards, 893 and 1,026 common shares were automatically withheld at a price of $56.03 per share, as described in the footnotes. After these transactions, Moschner held 16,465 shares of Cognex common stock directly, along with multiple outstanding non-qualified stock options and additional restricted stock units.
COGNEX CORP executive Joerg Kuechen reported option and RSU exercises alongside significant share sales. On February 20–21, 2026, he exercised multiple non-qualified stock options and restricted stock units, receiving Cognex common stock through derivative exercises at stated exercise prices such as $33.04, $38.39, and $39.44 per share.
He then sold a total of 61,900 shares of common stock in open-market transactions at prices around $55.98–$56.24, and some additional shares were disposed of to satisfy tax withholding obligations on vested restricted stock units, as described in the footnotes. After these transactions, Kuechen directly owned 6,032 shares of Cognex common stock.
Cognex EVP Carl Gerst reported a series of stock transactions involving Cognex common shares and restricted stock units. On February 20, 2026, he exercised restricted stock units into 6,846 common shares and another 6,846 common shares, then had 2,010 shares withheld to cover tax obligations and sold 3,804 shares in open‑market trades at about $55.99 per share. On February 21, 2026, additional restricted stock units converted into 8,791 common shares, with 3,095 shares withheld for taxes. On February 23, 2026, he sold 10,532 common shares in open‑market transactions at an average price of about $55.93 per share under a Rule 10b5‑1 trading plan. After these trades, his reported direct common‑stock holdings were 0 shares, while the filing notes outstanding restricted stock units that vest 20%, 30%, and 50% on the first, second, and third anniversaries of the 2023 and 2024 grant dates.
Cognex Corporation vice president and principal accounting officer Laura Ann Macdonald reported routine equity compensation activity. On February 20, 2026 and February 21, 2026, restricted stock units converted into 1,902 and 2,754 shares of common stock, respectively, through derivative exercises at a stated price of $0.00 per share.
To satisfy tax withholding obligations on these vestings, 559 and 809 common shares were automatically withheld at $56.03 per share, as described in the footnotes. Following these transactions, Macdonald directly held 7,211 Cognex common shares, along with multiple non-qualified stock option and restricted stock unit positions. An additional 20 common shares are held indirectly by her child, with beneficial ownership disclaimed except for any pecuniary interest.
Cognex Corporation executive Sheila Marie DiPalma, EVP of Employee Services, reported the vesting of restricted stock units and related tax withholding transactions. On February 20, 2026 and February 21, 2026, she acquired a total of 9,098 shares of common stock through exercises of restricted stock units, each unit converting into one share.
To cover tax withholding obligations on these vested awards, 1,117 shares on February 20, 2026 and 1,555 shares on February 21, 2026 were disposed of at $56.03 per share, as share-withholding rather than open-market sales. After these transactions, she directly owned 15,013 shares of Cognex common stock.
Cognex insider filing reports an intended sale of 10,532 shares of common stock under Rule 144. The filing lists aggregate value $590,107.96 and states shares outstanding were 165,707,920 as of 02/23/2026.
The excerpt also reports prior 10b5-1 sales by Carl W. Gerst III on 02/20/2026 of 3,804 shares for $212,979.49. Timing and method for the 10,532-share disposition are set out in the notice.
Company CGNX reported insider sale activity via a Form 144 notice. The filing lists 61,900 common shares and an aggregate amount of $3,468,385.93 tied to 02/20/2026 on NASDAQ. The excerpt also shows 2,729 restricted shares dated 02/18/2026 and 59,171 shares from a stock option exercise dated 02/20/2026.
COGNEX CORP director Dianne M. Parrotte reported equity award activity involving restricted stock units and common shares. On February 18, 2026, she exercised or converted 8,324 restricted stock units into 8,324 shares of Cognex common stock at a stated price of $0.00 per share, increasing her direct common stock holdings to 30,518 shares.
The filing also lists updated direct holdings of several non-qualified stock options with rights to buy 7,500, 18,400 and 18,100 shares, and 2,913 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Cognex common stock and vests 100% on the first anniversary of the grant date, stated as February 18, 2025.